U.S. appeals court blocks Indiana 'selective' abortion law

(Reuters) - A federal appeals court on Thursday declared unconstitutional an Indiana law signed by then-Governor Mike Pence that banned women from having abortions because of the gender, race or disability, including Down's syndrome, of their fetuses.

Novartis CEO feels heat on U.S. generics, Cosentyx drop

ZURICH (Reuters) - Swiss drugmaker Novartis' first quarterly results under new CEO Vas Narasimhan have been marred by a prized psoriasis treatment that disappointed and a sharp slump in sales by its U.S. generics unit.

Large spleen helps explain deep-diving skills of Southeast Asian 'sea nomads'

(Reuters Health) - An age-old nomadic community of Southeast Asian boat-dwellers who get their food from the sea appear to have evolved enlarged spleens that may help explain their extreme diving prowess, a new study suggests.

WHO recommends testing before use of Sanofi's dengue vaccine

PARIS/CHICAGO (Reuters) - The World Health Organization (WHO) said on Thursday Sanofi's vaccine against dengue should only be used after testing on individuals to assess whether they have ever been exposed to the infection.

Concussion raises Parkinson's disease risk in large U.S. study

(Reuters Health) - A new study of hundreds of thousands of U.S. armed forces veterans concludes that banging your head severely enough to lose consciousness can dramatically increase the risk of Parkinson's, the brain disease marked by tremors, slow movements, balance problems and difficulty walking.

FDA staff raises safety concerns over Lilly/Incyte arthritis drug

(Reuters) - An experimental rheumatoid arthritis drug developed by Eli Lilly and Co and Incyte Corp poses serious risks of deadly blood clots at higher doses, U.S. Food and Drug Administration staff said on Thursday, the latest setback to a treatment regulators declined to approve last year.

GW Pharma gets FDA panel nod, first cannabis-based drug nearing approval

(Reuters) - An advisory panel to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of approving the first cannabis-derived medicine in the country, a childhood epilepsy treatment developed by GW Pharma.

Improving overall heart health may reduce risk of atrial fibrillation

(Reuters Health) - Following practices recommended for "optimal" heart health may also reduce the risk of developing a serious heart-rhythm disorder, researchers say.

U.S. appeals court says Ohio cannot block Planned Parenthood funds

(Reuters) - A federal appeals court on Wednesday blocked an Ohio law that would cut federal taxpayer funding to 28 Planned Parenthood clinics, holding that conditions it imposed that denied funds to abortion providers were unconstitutional.

Gates backs gene technologies in fight to end malaria

LONDON, April 18 (Reuters) - Gene-editing technologies that alter mosquitoes' DNA could prove critical in the fight against malaria, Bill Gates said on Wednesday, and ethical concerns should not block progress in such gene-modifying research.

Related Videos

UK firm turns discarded gum into shoes, coffee cups, and combs

Chewing gum is a blight on city streets and takes a heavy toll on the environment, say its critics. But one woman in Britain is performing modern-day alchemy on it - Gumdrop founder Anna Bullus - as Amber Austin-Wright found out.

Plastic-eating enzyme holds promise in fighting pollution - scientists

Scientists in Britain and the United States say they have engineered a plastic-eating enzyme that could in future help in the fight against pollution. Stuart McDill reports.
You might like...

Check out our Reuters News Now daily briefing for hand-picked stories from Reuters editors. It's all the news you need to start your day.

Subscribe here